| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT06672523 A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of… |
date change Primary completion pushed: 2026-04-20 -> 2027-10-25 |
| 2026-06-09 | NCT06672523 A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of… |
date change Completion pushed: 2026-04-20 -> 2027-10-25 |
| 2026-06-06 | NCT07063745 A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and… |
Trial sites expanded: 288 -> 311 locations |
| 2026-06-04 | NCT07076121 A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-04 | NCT07076121 A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and… |
Trial sites reduced: 279 -> 269 locations |
| 2026-05-30 | NCT07492680 A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants… |
Trial sites expanded: 55 -> 58 locations |
| 2026-05-19 | NCT07063745 A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and… |
Trial sites expanded: 277 -> 288 locations |
| 2026-05-15 | NCT07544628 A Phase 1 Study of Navlimetostat Tablet Formulations |
Recruitment opened |
| 2026-05-15 | NCT07544628 A Phase 1 Study of Navlimetostat Tablet Formulations |
Trial sites expanded: 0 -> 3 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-22 | NCT07602946 SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial… | Phase 2 | Not Yet Recruiting |
| 2026-05-19 | NCT07594626 BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors… | Phase 1/2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT07063745 | A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and… | Metastatic Non-small Cell Lung Cancer With MTAP Deletion | Recruiting |
| NCT07076121 | A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and… | Pancreatic Ductal Adenocarcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT07283705 | A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer | Phase 2 Study | Recruiting |
| NCT06855771 | A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT07602946 | SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial… | Mesothelioma | Not Yet Recruiting |
| NCT07492680 | A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants… | Solid Tumors | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07549022 | Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor | Malignant Peripheral Nerve Sheath Tumors | Not Yet Recruiting |
| NCT07594626 | BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors… | Metastatic Biliary Tract Carcinoma | Not Yet Recruiting |
| NCT07579221 | Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell… | Non-Small Cell Lung Cancer | Not Yet Recruiting |
| Phase 1 | |||
| NCT07532902 | A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer | Diffuse Pleural Mesothelioma | Recruiting |
| NCT07544628 | A Phase 1 Study of Navlimetostat Tablet Formulations | Healthy Participants | Recruiting |
| NCT07077434 | A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in… | Advanced Solid Tumors | Recruiting |
| NCT06672523 | A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of… | Advanced Solid Tumors With Homozygous MTAP Deletion | Recruiting |